172 related articles for article (PubMed ID: 10891967)
1. Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations.
Yancey KB; Egan CA
JAMA; 2000 Jul; 284(3):350-6. PubMed ID: 10891967
[TBL] [Abstract][Full Text] [Related]
2. Bullous pemphigoid and related subepidermal autoimmune blistering diseases.
Olasz EB; Yancey KB
Curr Dir Autoimmun; 2008; 10():141-66. PubMed ID: 18460884
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
[TBL] [Abstract][Full Text] [Related]
4. [Autoimmune bullous skin disorders].
Hertl M; Niedermeier A; Borradori L
Ther Umsch; 2010 Sep; 67(9):465-82. PubMed ID: 20806175
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of Disease: Pemphigus and Bullous Pemphigoid.
Hammers CM; Stanley JR
Annu Rev Pathol; 2016 May; 11():175-97. PubMed ID: 26907530
[TBL] [Abstract][Full Text] [Related]
6. Childhood Bullous Pemphigoid: A Treatment Challenge.
Ayala-Cortés AS; Martínez-Cabriales SA; Welsh O; Rosales-Solis G; Vázquez-Martínez O; Ocampo-Candiani J
J Pediatr; 2016 Dec; 179():271-271.e1. PubMed ID: 27697329
[No Abstract] [Full Text] [Related]
7. IgG4, complement, and the mechanisms of blister formation in pemphigus and bullous pemphigoid.
Dainichi T; Chow Z; Kabashima K
J Dermatol Sci; 2017 Dec; 88(3):265-270. PubMed ID: 28747266
[TBL] [Abstract][Full Text] [Related]
8. Management of bullous pemphigoid: recommendations for immunomodulatory treatments.
Kirtschig G; Khumalo NP
Am J Clin Dermatol; 2004; 5(5):319-26. PubMed ID: 15554733
[TBL] [Abstract][Full Text] [Related]
9. Subepidermal blistering disease with autoantibodies to both the p200 autoantigen and the alpha3 chain of laminin 5.
Shimanovich I; Petersen EE; Weyers W; Sitaru C; Zillikens D
J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S90-2. PubMed ID: 15858518
[TBL] [Abstract][Full Text] [Related]
10. Targeted Therapies for Autoimmune Bullous Diseases: Current Status.
Amber KT; Maglie R; Solimani F; Eming R; Hertl M
Drugs; 2018 Oct; 78(15):1527-1548. PubMed ID: 30238396
[TBL] [Abstract][Full Text] [Related]
11. Bullous pemphigoid treatment review.
Patton T; Korman NJ
Expert Opin Pharmacother; 2006 Dec; 7(17):2403-11. PubMed ID: 17109614
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and classification of pemphigus and bullous pemphigoid.
Kershenovich R; Hodak E; Mimouni D
Autoimmun Rev; 2014; 13(4-5):477-81. PubMed ID: 24424192
[TBL] [Abstract][Full Text] [Related]
13. Bullous pemphigoid and pemphigus vulgaris.
Patel HP; Anhalt GJ; Diaz LA
Ann Allergy; 1983 Mar; 50(3):144-50. PubMed ID: 6338766
[No Abstract] [Full Text] [Related]
14. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Bonsmann G; Luger TA
Arch Dermatol; 2007 Dec; 143(12):1536-42. PubMed ID: 18087004
[TBL] [Abstract][Full Text] [Related]
15. Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment.
Bernard P; Antonicelli F
Am J Clin Dermatol; 2017 Aug; 18(4):513-528. PubMed ID: 28247089
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin.
Sitaru C; Schmidt E; Petermann S; Munteanu LS; Bröcker EB; Zillikens D
J Invest Dermatol; 2002 Apr; 118(4):664-71. PubMed ID: 11918714
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of pemphigus foliaceus and bullous pemphigoid. Demonstration of autoantibodies that bind to both the pemphigus foliaceus antigen complex and the bullous pemphigoid antigen.
Korman NJ; Stanley JR; Woodley DT
Arch Dermatol; 1991 Mar; 127(3):387-90. PubMed ID: 1998370
[TBL] [Abstract][Full Text] [Related]
18. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
[TBL] [Abstract][Full Text] [Related]
19. Changes in the autoimmune blistering response: a clinical and immunopathological shift from pemphigus foliaceus to bullous pemphigoid.
Maeda JY; Moura AK; Maruta CW; Santi CG; Prisayanh PS; Aoki V
Clin Exp Dermatol; 2006 Sep; 31(5):653-5. PubMed ID: 16901304
[TBL] [Abstract][Full Text] [Related]
20. A Retrospective Study of Patient-Reported Data of Bullous Pemphigoid and Mucous Membrane Pemphigoid From a US-Based Registry.
Lee J; Seiffert-Sinha K; Attwood K; Sinha AA
Front Immunol; 2019; 10():2219. PubMed ID: 31608053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
